Finance

Lists
ANIK:NASDAQ
Anika Therapeutics Inc
US$20,39
-0,68%
(-0,14) 1D
14 ຕ.ລ., 11 ໂມງ 11 ນາທີ 33 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANIK...
Open
US$20,34
High
US$20,61
Low
US$20,25
Mkt. cap
272,88 ລ້ານ
Avg. vol.
89,24 ພັນ
Volume
10,05 ພັນ
52-wk high
US$22,88
52-wk low
US$8,67
EPS
US$-0,27
Beta
0,21
Shares outstanding
13,38 ລ້ານ
No. of employees
235
Open
US$20,34
High
US$20,61
Low
US$20,25
Mkt. cap
272,88 ລ້ານ
Avg. vol.
89,24 ພັນ
Volume
10,05 ພັນ
52-wk high
US$22,88
52-wk low
US$8,67
EPS
US$-0,27
Beta
0,21
Shares outstanding
13,38 ລ້ານ
No. of employees
235
News stories
From web sources and news partners
Local 3 News
Local 3 News
·
1 ຊົ່ວໂມງກ່ອນ
RAW: NYSE: OPENING BELL (WEDNESDAY)
Central Oregon Daily
Central Oregon Daily
·
32 ນາທີກ່ອນ
Wall St slides as hot CPI data fuels rate-hike bets; chips, banks weigh
About Anika Therapeutics Inc
CEO-
Employees235
Founded1983
HeadquartersBedford, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorBiotechnology
Websiteanika.com
Analyst ratings
Based on 2 analysts giving stock ratings to ANIK in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ANIK in the last 3 months.
Highest
Current US$20,39
US$23,00 (+12,80%)
Average
US$23,00 (+12,80%)
Lowest
US$23,00 (+12,80%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Petusky
Barrington
Buy
Maintained
US$23,00
+12,8%
10/01/2026
Madison Elsaadi
B. Riley Securities
Buy
Initiated
US$23,00
+12,8%
09/18/2026
Anderson Schock
B. Riley Securities
Buy
Maintained
US$21,00
+3%
07/30/2026
Last report
29 ກ.ລ. 2026
Fiscal period
Q2 2026
US$0,42 / US$0,03
+1.300,00%beat
Revenue / Est. (USD)
32,61 ລ້ານ / 29,21 ລ້ານ
+11,62%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
27,82 ລ້ານ
30,62 ລ້ານ
29,61 ລ້ານ
32,61 ລ້ານ
Cost of goods sold
12,23 ລ້ານ
11,44 ລ້ານ
10,62 ລ້ານ
11,37 ລ້ານ
Cost of revenue
12,23 ລ້ານ
11,44 ລ້ານ
10,62 ລ້ານ
11,37 ລ້ານ
Research and development expenses
6,95 ລ້ານ
6,45 ລ້ານ
6,71 ລ້ານ
7,34 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,87 ລ້ານ
12,08 ລ້ານ
16,18 ລ້ານ
10,18 ລ້ານ
Operating expense
18,82 ລ້ານ
18,53 ລ້ານ
22,90 ລ້ານ
17,52 ລ້ານ
Total operating expenses
31,05 ລ້ານ
29,97 ລ້ານ
33,51 ລ້ານ
28,88 ລ້ານ
Operating income
-3,23 ລ້ານ
646,00 ພັນ
-3,90 ລ້ານ
3,73 ລ້ານ
Other non operating income
-
-
-
-
EBT including unusual items
-2,24 ລ້ານ
764,00 ພັນ
-4,82 ລ້ານ
3,38 ລ້ານ
EBT excluding unusual items
-2,24 ລ້ານ
764,00 ພັນ
-3,23 ລ້ານ
4,15 ລ້ານ
Income tax expense
939,00 ພັນ
-1,04 ລ້ານ
235,00 ພັນ
71,00 ພັນ
Effective tax rate
-41,99%
-135,73%
-4,87%
2,10%
Other operating expenses
-
-
-
-
Net income
-2,33 ລ້ານ
292,00 ພັນ
-5,06 ລ້ານ
3,31 ລ້ານ
Net profit margin
-8,37%
0,95%
-17,07%
10,15%
Earnings per share
0,04
0,31
0,27
0,42
Interest and investment income
997,00 ພັນ
118,00 ພັນ
667,00 ພັນ
426,00 ພັນ
Interest expense
-
-
-
-
Net interest expenses
997,00 ພັນ
118,00 ພັນ
667,00 ພັນ
426,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,83 ລ້ານ
1,96 ລ້ານ
-2,49 ລ້ານ
5,23 ລ້ານ
Gain or loss from assets sale
-451,00 ພັນ
790,00 ພັນ
-52,00 ພັນ
-32,00 ພັນ
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google